Baylor University

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Idiopathic pulmonary fibrosis1 trial
• Melanoma1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Completed1 trial
• Recruiting1 trial

Lead sponsor

• Immatics US, Inc.1 trial
• Nerre Therapeutics Ltd.1 trial

Running trials

• Recruiting

  SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma

  NCT06743126· Phase 3· Immatics US, Inc.· Source

  Contact: Charles (Lance) Cowey, MD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Melanoma1 recruiting

Closed trials

• Completed

  Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis

  NCT05185089· Phase 2· Nerre Therapeutics Ltd.· Source